TOP 2021 companies: the CEO of AROMICS among the most outstanding professionals in business

Imagen Noticia

Detail of the short interview with Dr. Carmen Plasencia, CEO and co-founder of AROMICS. The interview published last June 27, 2021 in the weekly supplement of Empresa of the ABC newspaper, allows readers to understand the main keys of the developments made in this small biotech from Barcelona, which are mainly focused on the progress towards the clinic of a new antitumor to combat a complex and resistant cancer: malignant mesothelioma. Also known as asbestos cancer, due to its direct relationship with the inhalation of fibers of this material widely used in construction until 2002.  The development of Aromics has received support from the European Union's Horizon 2020 program. For more information, see the Bermes Project website


  download associated file